ResMed | RMD - Sales Revenues

Stock Price
37.92
Daily Change
0.46 1.23%
Monthly
3.89%
Yearly
0.61%
Q1 Forecast
36.78

ResMed reported $1.42B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Ansell USD 834.4M 49.5M Jun/2024
Avita Medical AUD 18.42M 14K Jun/2025
Cochlear AUD 585.65M 586.15M Jun/2025
CSL USD 3.54B 4.68B Jun/2025
Fisher & Paykel Healthcare NZD 1.09B 9.2M Sep/2025
Healius AUD 933.9M 485.3M Dec/2024
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 195.04M 20.71M Jun/2025
Nanosonics AUD 105.03M 11.44M Jun/2025
Polynovo AUD 34.58M 24.94M Jun/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
Regis Healthcare AUD 619.06M 37.36M Dec/2024
ResMed USD 1.42B 87.23M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Sonic Healthcare AUD 4.98B 311M Jun/2025
Telix Pharmaceuticals AUD 309.72M 109.32M Jun/2025